Breastfeeding warning
Use during breastfeeding only on medical advice.
Leaflet DARUNAVIR GLENMARK 600mg film-coated tablets
Precautions:
Pregnancy warning
Use during pregnancy only on medical advice.
Darunavir is a protease inhibitor used for the treatment of human immunodeficiency virus (HIV) infection. It works by inhibiting the HIV protease enzyme, which is essential for viral replication, thereby reducing the viral load.
The medication is taken orally, usually once daily, in combination with other antiretroviral drugs. Common side effects include nausea, diarrhea, headaches, and skin rashes.
Darunavir is contraindicated in patients with hypersensitivity to the active substance or any of its excipients. It should also be used with caution in patients with severe hepatic conditions.
This medication is an important option for managing HIV infection, helping to improve patients' quality of life and prevent disease progression.
The medication is taken orally, usually once daily, in combination with other antiretroviral drugs. Common side effects include nausea, diarrhea, headaches, and skin rashes.
Darunavir is contraindicated in patients with hypersensitivity to the active substance or any of its excipients. It should also be used with caution in patients with severe hepatic conditions.
This medication is an important option for managing HIV infection, helping to improve patients' quality of life and prevent disease progression.
General data about DARUNAVIR GLENMARK 600mg
- Substance:
- darunavir
- Date of latest medicines list:
- 01-10-2020
- Product code:
- W66884001
- Concentration:
- 600mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 60
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for darunavir
Concentrations available for darunavir
- 100mg/ml
- 150mg
- 300mg
- 400mg
- 600mg
- 75mg
- 800mg